Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
- PMID: 37651097
- DOI: 10.1097/MAT.0000000000001984
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Abstract
Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported. We describe a cohort of patients supported by left ventricular assist devices (LVADs) presenting to the emergency department (ED) at a high-volume LVAD center while in awake ventricular fibrillation (VF)/ventricular tachycardia (VT). Among 175 patients reviewed, a total of 19 LVAD patients presented to the ED in awake VF/VT between December 2015 and July 2021. On ED presentation, patients maintained a median mean arterial blood pressure (MAP) of 70 mm Hg with a mean LVAD flow of 3.77 L/minute. ED management included cardioversion in the majority of cases: 58% were defibrillated once, 21% were defibrillated multiple times, 68% received amiodarone, and 21% received lidocaine. Inpatient management included defibrillation, ablation, and antiarrhythmic initiation in 37%, 11%, and 84% of cases, respectively. In total, five patients (26%) died with one death attributed to recurrent VT. Our findings support the short-term tolerability of sustained ventricular arrhythmias in LVAD patients, as evidenced by the maintained MAPs and mental status. Clinical teams, however, should be aware of the potential harbinger for in-hospital mortality heralded by an awake VF/VT presentation.
Copyright © ASAIO 2023.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to report.
References
-
- Tsao CW, Aday AW, Almarzooq ZI, et al.: Heart Disease and Stroke Statistics-2022 update: A report from the American Heart Association. Circulation. 145: e153–e639, 2022.
-
- Sanaiha Y, Downey P, Lyons R, Nsair A, Shemin RJ, Benharash P: Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States. J Thorac Cardiovasc Surg. 161: 2083–2091.e4, 2021.
-
- Trachtenberg BH, Estep JD: Roads, maps, and destinations: The journey of left ventricular assist device implantation in ambulatory patients with advanced heart failure. Curr Cardiol Rep. 18: 132, 2016.
-
- Kormos RL, Cowger J, Pagani FD, et al.: The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 38: 114–126, 2019.
-
- Gopinathannair R, Cornwell WK, Dukes JW, et al.: Device therapy and arrhythmia management in left ventricular assist device recipients: A scientific statement from the American Heart Association. Circulation. 139: e967–e989, 2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources